Iovance Biotherapeutics Inc. buy Truist Financial Co.
Start price
27.12.23
/
50%
€6.20
Target price
27.12.24
€15.35
Performance (%)
70.35%
Price
30.08.24
€10.56
Summary
This prediction is currently active. With a performance of 70.35% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 27.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | -0.518% | -0.518% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $17.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.09
15.09.23
15.09.23
€15.92
15.09.24
15.09.24
107.37%
30.08.24
30.08.24